Skip to content

PRESSURE BIOSCIENCES, INC.: 10-Q filed 2011-11-14

What PRESSURE BIOSCIENCES, INC. reported in its quarterly report filed 2011-11-14 (fiscal Q3 2011): 32 published measures, 82 facts as tagged in accession 0000830656-11-000047.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-14
Fiscal period
fiscal Q3 2011
Accession
0000830656-11-000047 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PRESSURE BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-301,925,222USD
At 2010-12-312,590,606USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-09-301,779,834USD
At 2010-12-31781,097USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-30145,388USD
At 2010-12-311,809,509USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-09-30296,970USD
At 2010-12-31552,849USD
At 2010-09-30948,550USD
At 2009-12-311,609,778USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-561,723USD92
2011-01-01 to 2011-09-30-2,153,269USD273
2010-07-01 to 2010-09-30-597,670USD92
2010-01-01 to 2010-09-30-2,305,646USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-1,529,950USD273
2010-01-01 to 2010-09-30-2,461,421USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-09-300USD273
2010-01-01 to 2010-09-3086,949USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-09-301,274,071USD273
2010-01-01 to 2010-09-301,887,142USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-300USD273
2010-01-01 to 2010-09-30-86,949USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-30-14,545,260USD
At 2010-12-31-11,565,263USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-07-01 to 2011-09-300USD92
2011-01-01 to 2011-09-300USD273
2010-07-01 to 2010-09-30-244,479USD92
2010-01-01 to 2010-09-30-244,479USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-3098,181USD
At 2010-12-31192,777USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-09-30113,689USD273
2010-01-01 to 2010-09-30227,476USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-745,811USD92
2011-01-01 to 2011-09-30-2,421,707USD273
2010-07-01 to 2010-09-30-842,587USD92
2010-01-01 to 2010-09-30-2,551,685USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-301,681,121USD
At 2010-12-312,215,435USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-301,770,504USD
At 2010-12-31771,670USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-09-30658,977USD
At 2010-12-31234,568USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-30115,028USD
At 2010-12-31233,846USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-07-01 to 2011-09-301,026,233USD92
2011-01-01 to 2011-09-303,073,458USD273
2010-07-01 to 2010-09-301,214,690USD92
2010-01-01 to 2010-09-303,616,705USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-09-301,129,662USD
At 2010-12-311,104,056USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-07-01 to 2011-09-30248,188USD92
2011-01-01 to 2011-09-30730,962USD273
2010-07-01 to 2010-09-30382,054USD92
2010-01-01 to 2010-09-30980,338USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-09-306,353,016shares
At 2010-12-312,711,750shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-09-3012,802,216USD
At 2010-12-3112,095,237USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-09-30145,920USD
At 2010-12-31182,394USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-09-30304,183USD
At 2010-12-31337,698USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-09-30128,250USD
At 2010-12-31296,756USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-561,723USD92
2011-01-01 to 2011-09-30-2,153,269USD273
2010-07-01 to 2010-09-30-842,149USD92
2010-01-01 to 2010-09-30-2,550,125USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-953,846USD92
2011-01-01 to 2011-09-30-3,092,843USD273
2010-07-01 to 2010-09-30-692,875USD92
2010-01-01 to 2010-09-30-2,714,413USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30490,460USD92
2011-01-01 to 2011-09-301,351,303USD273
2010-07-01 to 2010-09-30432,939USD92
2010-01-01 to 2010-09-301,445,742USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-01-01 to 2011-09-30109,520USD273
2010-01-01 to 2010-09-30149,265USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-118,818USD273
2010-01-01 to 2010-09-309,579USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-304,056USD273
2010-01-01 to 2010-09-30494,470USD273

Inspect the source

Entity
PRESSURE BIOSCIENCES, INC. / CIK 0000830656
Captured
2026-09-21T17:17:15.791Z
SEC response SHA-256
9f53d6670ff4d2eff56cabbc6920a9205a8540e6e5042ac9d3ad7d038501b96e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000830656.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))